Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now renders a 403 Forbidden error, blocking access to the study record. Visible content such as study details and linked documents is no longer accessible on this page.SummaryDifference24%

- Check22 days agoChange DetectedThis change removes the phrase 'Multiple myeloma' from the study page and deletes the related topics section including the MedlinePlus Genetics link.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a backend/template update to the study page. The visible content remains unchanged.SummaryDifference0.0%

- Check57 days agoChange DetectedThe study page now includes the disease term Multiple myeloma and a related topics link to MedlinePlus Genetics, improving context and discoverability. The revision tag has been updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check64 days agoChange DetectedA Study Documents section was added with links to PDFs (Study Protocol, SAP) and information about IPD sharing. It also includes an IPD Sharing URL and related resources, expanding access to documentation and data-sharing details for researchers and interested readers.SummaryDifference94%

- Check71 days agoChange DetectedThe page shows a new Revision: v3.6.4, indicating a site update; older study documents and related links were removed as part of that update.SummaryDifference23%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.